Robert Swinney Biography and Net Worth

Director of ICU Medical


Dr. Robert S. Swinney M.D. serves as Independent Director of the Company. Dr. Swinney serves as Chair of the Compensation Committee and is a member of the Nominating Governance Committee and previously served as a director from 1989 to October 1995. Dr. Swinney has more than 30 years of experience as a critical care physician in a large, public teaching hospital, where he has formerly served as the critical care unit director and Chair of the ICU Committee. Dr. Swinney also has experience in private primary care practice and emergency medicine. He holds two patents for medical products and, in his daily work, was frequently called upon to examine and evaluate new medical products. The Board benefits from Dr. Swinney’s medical and leadership experience, including Dr. Swinney’s work with patents, which has provided him with a high level of technical expertise, enabling him to evaluate new developments in medical technology in light of his long-term evaluation of advances. The Board believes Dr. Swinney should serve as a director due to his medical and leadership experience, including Dr. Swinney’s work with patents, which has provided him with a high level of technical expertise, which enables him to evaluate new developments in medical technology.

What is Robert S. Swinney's net worth?

The estimated net worth of Robert S. Swinney is at least $3.57 million as of October 16th, 2020. Dr. Swinney owns 22,782 shares of ICU Medical stock worth more than $3,569,712 as of December 26th. This net worth estimate does not reflect any other investments that Dr. Swinney may own. Learn More about Robert S. Swinney's net worth.

How do I contact Robert S. Swinney?

The corporate mailing address for Dr. Swinney and other ICU Medical executives is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. ICU Medical can also be reached via phone at (949) 366-2183 and via email at [email protected]. Learn More on Robert S. Swinney's contact information.

Has Robert S. Swinney been buying or selling shares of ICU Medical?

Robert S. Swinney has not been actively trading shares of ICU Medical within the last three months. Most recently, Robert S. Swinney sold 1,500 shares of the business's stock in a transaction on Tuesday, March 2nd. The shares were sold at an average price of $207.00, for a transaction totalling $310,500.00. Learn More on Robert S. Swinney's trading history.

Who are ICU Medical's active insiders?

ICU Medical's insider roster includes Elisha Finney (Director), Vivek Jain (CEO & Chairman of the Board), George Lopez (Director), Virginia Sanzone (VP), Robert Swinney (Director), Christian Voigtlander (COO), and Daniel Woolson (Corporate Vice President and General Manager, Infusion Systems). Learn More on ICU Medical's active insiders.

Are insiders buying or selling shares of ICU Medical?

In the last year, insiders at the medical instruments supplier sold shares 17 times. They sold a total of 108,017 shares worth more than $15,499,225.67. The most recent insider tranaction occured on December, 2nd when CEO Vivek Jain sold 12,000 shares worth more than $1,954,920.00. Insiders at ICU Medical own 6.7% of the company. Learn More about insider trades at ICU Medical.

Information on this page was last updated on 12/2/2024.

Robert S. Swinney Insider Trading History at ICU Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/2/2021Sell1,500$207.00$310,500.00
10/16/2020Sell277$202.22$56,014.9422,782View SEC Filing Icon  
7/16/2020Sell300$188.46$56,538.0021,582View SEC Filing Icon  
4/6/2020Sell1,500$207.15$310,725.0021,204View SEC Filing Icon  
1/30/2020Sell268$184.07$49,330.7619,972View SEC Filing Icon  
10/14/2019Sell373$153.49$57,251.7718,845View SEC Filing Icon  
8/15/2019Sell2,078$165.18$343,244.0417,345View SEC Filing Icon  
7/15/2019Sell239$248.73$59,446.4719,662View SEC Filing Icon  
4/12/2019Sell229$231.43$52,997.4718,076View SEC Filing Icon  
3/15/2019Sell1,464$234.65$343,527.6016,576View SEC Filing Icon  
1/28/2019Sell1,500$242.19$363,285.0019,540View SEC Filing Icon  
6/11/2018Sell343$290.95$99,795.8518,383View SEC Filing Icon  
1/19/2018Sell724$235.00$170,140.0014,830View SEC Filing Icon  
11/28/2017Sell1,000$215.10$215,100.0013,330View SEC Filing Icon  
9/15/2017Sell463$181.25$83,918.7514,330View SEC Filing Icon  
9/1/2017Sell3,400$175.01$595,034.0015,193View SEC Filing Icon  
8/31/2017Sell3,400$173.98$591,532.0020,893View SEC Filing Icon  
7/20/2017Sell4,477$175.00$783,475.0023,293View SEC Filing Icon  
5/17/2017Sell594$160.92$95,586.4814,793View SEC Filing Icon  
3/13/2017Sell646$155.09$100,188.1414,644View SEC Filing Icon  
3/10/2017Sell1,235$151.23$186,769.0516,325View SEC Filing Icon  
11/14/2016Sell2,025$142.88$289,332.0016,850View SEC Filing Icon  
5/9/2016Sell1,875$101.40$190,125.0019,633View SEC Filing Icon  
4/11/2016Sell1,875$101.35$190,031.2519,633View SEC Filing Icon  
11/25/2015Sell3,000$112.00$336,000.0017,758View SEC Filing Icon  
3/12/2015Sell3,094$90.92$281,306.48View SEC Filing Icon  
8/15/2014Sell1,475$62.70$92,482.50View SEC Filing Icon  
See Full Table

Robert S. Swinney Buying and Selling Activity at ICU Medical

This chart shows Robert S Swinney's buying and selling at ICU Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ICU Medical Company Overview

ICU Medical logo
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Read More

Today's Range

Now: $156.69
Low: $155.63
High: $157.24

50 Day Range

MA: $167.36
Low: $153.20
High: $180.94

2 Week Range

Now: $156.69
Low: $86.80
High: $196.26

Volume

33,690 shs

Average Volume

269,880 shs

Market Capitalization

$3.84 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62